|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Do oral contraceptives need to be interrupted in order to treat vaginal |
| Journal of the American Medical Women's Association 28(4): 198-200. April 1973. |
| A project was undertaken to determine whether there is any difference in treatment results of vaginal candidiasis in |
| women who use birth control pills and in women who do not use birth control pills. 110 women who had vaginal |
| discharge or itching and vaginal cultures for candida albicans were included in the study. 55 of the women were |
| taking birth control pills and 55 were not. Of the 55 women on birth control pills, 22 continued to have positive |
| cultures after using 15 nystatin (Mycostatin) suppositories as compared with 24 women who were not pill-users. Both |
| pill and non-pill users improved symptomatically after the use of the suppositories. 15 women on the pill whose |
| cultures had remained positive after using the nystatin suppositories were given another course of suppositories in |
| addition to nystatin oral tablets. Of these 15, 6 continued to have positive cultures. 16 non-pill-users with positive |
| cultures following the first course of suppositories were given a second course of suppositories in addition to the 30 |
| nystatin (Mycostatin) tablets. Of these 16, 5 continued to have positive cultures. 18 women were cultured 3 months |
| after their last culture. 10 of the 18 taking contraceptive pills were again positive. Of these, 8 had been negative after |
| treatment. The other 2 had had positive cultures but were asymptomatic after treatment. 8 had negative cultures. |
| 18 women not taking the contraceptive pills were also cultured 3 months after their last culture. 11 of these were |
| positive again. 9 of them had had a previous negative culture after treatment. 7 still had negative cultures. From this |
| series it appears that treatment of vaginal candidiasis is not made more difficult by the use of birth control pills. |
| From the data one cannot conclude that discontinuing birth control pills would facilitate treatment of vaginal |
| candidiasis. (PubHealth.info Document ID: CONT8T 552-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Do oral contraceptives need to be interrupted in order to |
| treat vaginal candidiasis?", is(are) Justin RG. The source of this article is "Journal of the American Medical |
| Women's Association 28(4): 198-200. April 1973.". This article was published in 1973 in English language(s). |
| (PubHealth.info® Document ID: CONT8T 552-06. All rights reserved with PubHealth.info) PIN: 35552 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |